| Ga-68-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis |
41 |
| Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States |
33 |
| Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists |
32 |
| Validation of the Clavien-Dindo Grading System in Urology by the European Association of Urology Guidelines Ad Hoc Panel |
28 |
| The Urinary Tract Microbiome in Health and Disease |
22 |
| Role of Restaging Transurethral Resection for T1 Non-muscle invasive Bladder Cancer: A Systematic Review and Meta-analysis |
21 |
| Grading of Urothelial Carcinoma and The New World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016 |
20 |
| European Association of Urology Guidelines on Renal Transplantation: Update 2018 |
20 |
| Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review |
19 |
| MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma |
18 |
| Perceived Role of Social Media in Urologic Knowledge Acquisition Among Young Urologists: A European Survey |
17 |
| Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis |
17 |
| Systematic Review of the Volume-Outcome Relationship for Radical Prostatectomy |
16 |
| PD-L1 Expression and CD8(+) T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate Cancer |
16 |
| Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma |
16 |
| Novel System for Robotic Single-port Surgery: Feasibility and State of the Art in Urology |
15 |
| Standard of Care Versus Metastases-directed Therapy for PET-detected Nodal Oligorecurrent Prostate Cancer Following Multimodality Treatment: A Multi-institutional Case-control Study |
14 |
| Robot-assisted Kidney Transplantation with Regional Hypothermia Using Grafts with Multiple Vessels After Extracorporeal Vascular Reconstruction: Results from the European Association of Urology Robotic Urology Section Working Group |
14 |
| The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy |
12 |
| Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin |
12 |
| Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis |
12 |
| Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine |
12 |
| Urology Residency Training in Italy: Results of the First National Survey |
11 |
| The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis |
11 |
| Differences in Trial and Real-world Populations in the Dutch Castration-resistant Prostate Cancer Registry |
11 |
| Medium-term Follow-up of Vascular-targeted Photodynamic Therapy of Localized Prostate Cancer Using TOOKAD Soluble WST-11 (Phase II Trials) |
11 |
| Correlation Between Confocal Laser Endomicroscopy (Cellvizio (R)) and Histological Grading of Upper Tract Urothelial Carcinoma: A Step Forward for a Better Selection of Patients Suitable for Conservative Management |
11 |
| Trends in Utilization of Robotic and Open Partial Nephrectomy for Management of cT1 Renal Masses |
11 |
| Current Use of Three-dimensional Model Technology in Urology: A Road Map for Personalised Surgical Planning |
10 |
| Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review |
10 |
| The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort |
10 |
| Background and Update for S1602 A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naive High-grade Non-muscle-invasive Bladder Cancer |
10 |
| Manufacturing and the Market: Rationalizing the Shortage of Bacillus Calmette-Guerin |
9 |
| Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naive and CYP17 Inhibitor-naive Patients: Follow-up from the ARADES and ARAFOR Trials |
9 |
| Prognostic Value of Androgen Receptor Splice Variant 7 in the Treatment of Castration-resistant Prostate Cancer with Next generation Androgen Receptor Signal Inhibition: A Systematic Review and Meta-analysis |
9 |
| The Stockholm-3 (STHLM3) Model can Improve Prostate Cancer Diagnostics in Men Aged 50-69 yr Compared with Current Prostate Cancer Testing |
9 |
| Intraoperative Imaging Techniques to Support Complete Tumor Resection in Partial Nephrectomy |
9 |
| The Urinary Tract Microbiome: The Answer to All Our Open Questions? |
9 |
| Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer: A Meta-analysis of Randomized Noninferiority Trials |
9 |
| Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment |
9 |
| Oestradiol-releasing Biodegradable Mesh Stimulates Collagen Production and Angiogenesis: An Approach to Improving Biomaterial Integration in Pelvic Floor Repair |
9 |
| Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer |
8 |
| The Harms of Overdiagnosis and Overtreatment in Patients with Small Renal Masses: A Mini-review |
8 |
| Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis |
8 |
| Biological Evolution of Castration-resistant Prostate Cancer |
8 |
| Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms |
8 |
| Risk of Upgrading and Upstaging Among 10 000 Patients with Gleason 3+4 Favorable Intermediate-risk Prostate Cancer |
8 |
| Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up |
8 |
| A Simplified Frailty Index to Predict Outcomes After Radical Cystectomy |
8 |
| Urinary Biomarkers in Overactive Bladder: Revisiting the Evidence in 2019 |
8 |
